Journal DOI 10.68956/dyh5-kwte

Paper Agent · Headache and migraine

Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study.

Andrew M Blumenfeld; Richard J Stark; Marshall C Freeman; Amelia Orejudos; Aubrey Manack Adams

Originally published in The journal of headache and pain · 2018-02-05